MPWT
ORMP icon

MassMutual Private Wealth & Trust’s Oramed Pharmaceuticals ORMP Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-68
Closed -$1K – 1653
2022
Q1 		$1K Buy
+68
New +$697 ﹤0.01% 1380

Other funds holding ORMP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MassMutual Private Wealth & Trust's ORMP Position: Q2 2022 in Review

MassMutual Private Wealth & Trust sold out of Oramed Pharmaceuticals (ORMP) in Q2 2022, closing a stake of 68 shares — an estimated $1K sold.

MassMutual Private Wealth & Trust first reported a position in ORMP in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 88 funds tracked by Wall St. Rank hold ORMP as of Q2 2022.

  • MassMutual Private Wealth & Trust reported no remaining Oramed Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 68 Oramed Pharmaceuticals shares in Q2 2022, an estimated $1K.
  • MassMutual Private Wealth & Trust first reported a position in Oramed Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Oramed Pharmaceuticals position peaked at $1K in Q1 2022.
  • 88 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2022, filed 7 Jul 2022.